78 related articles for article (PubMed ID: 7930614)
21. Phase 1, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer.
Agarwala SS; Kirkwood JM; Bryant J
Cytokines Cell Mol Ther; 2000 Dec; 6(4):171-6. PubMed ID: 11565955
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cells induce activated murine B cells to secrete Ig.
Snapper CM; Yamaguchi H; Moorman MA; Sneed R; Smoot D; Mond JJ
J Immunol; 1993 Nov; 151(10):5251-60. PubMed ID: 8228222
[TBL] [Abstract][Full Text] [Related]
23. B cell responses to a peptide epitope. VI. The kinetics of antigen recognition modulates B cell-mediated recruitment of T helper subsets.
Vijayakrishnan L; Manivel V; Rao KV
J Immunol; 1998 Nov; 161(9):4661-70. PubMed ID: 9794395
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of Francisella tularensis lipopolysaccharide on B lymphocytes.
Rahhal RM; Vanden Bush TJ; McLendon MK; Apicella MA; Bishop GA
J Leukoc Biol; 2007 Oct; 82(4):813-20. PubMed ID: 17634278
[TBL] [Abstract][Full Text] [Related]
26. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
[TBL] [Abstract][Full Text] [Related]
27. 7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine.
Pope BL; Sigindere J; Chourmouzis E; MacIntyre P; Goodman MG
Cancer Immunol Immunother; 1994 Feb; 38(2):83-91. PubMed ID: 8306370
[TBL] [Abstract][Full Text] [Related]
28. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation.
Lycke NY
J Immunol; 1993 Jun; 150(11):4810-21. PubMed ID: 8388421
[TBL] [Abstract][Full Text] [Related]
29. A role for T cell CD4 in contact mediated T dependent B cell activation.
Kruman II; Ramiya V; Bondada S
Cell Immunol; 1996 Nov; 173(2):236-45. PubMed ID: 8912882
[TBL] [Abstract][Full Text] [Related]
30. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily.
Heil F; Ahmad-Nejad P; Hemmi H; Hochrein H; Ampenberger F; Gellert T; Dietrich H; Lipford G; Takeda K; Akira S; Wagner H; Bauer S
Eur J Immunol; 2003 Nov; 33(11):2987-97. PubMed ID: 14579267
[TBL] [Abstract][Full Text] [Related]
31. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
Lian RH; Freeman JD; Mager DL; Takei F
J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
[TBL] [Abstract][Full Text] [Related]
32. PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA.
Shen E; Li L; Li L; Feng L; Lu L; Yao Z; Lin H; Wu C
Cell Mol Immunol; 2007 Apr; 4(2):113-20. PubMed ID: 17484805
[TBL] [Abstract][Full Text] [Related]
33. Whole-body autoradiography reveals that the Peptostreptococcus magnus immunoglobulin-binding domains of protein L preferentially target B lymphocytes in the spleen and lymph nodes in vivo.
Smith D; D'Argy R; Nilsson M; Yrlid U; de Jersey J; Björck L; Wick MJ
Cell Microbiol; 2004 Jul; 6(7):609-23. PubMed ID: 15186398
[TBL] [Abstract][Full Text] [Related]
34. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
Singh N; Hong S; Scherer DC; Serizawa I; Burdin N; Kronenberg M; Koezuka Y; Van Kaer L
J Immunol; 1999 Sep; 163(5):2373-7. PubMed ID: 10452969
[TBL] [Abstract][Full Text] [Related]
35. Antibody class switching differs among SJL, C57BL/6 and 129 mice.
Kaminski DA; Stavnezer J
Int Immunol; 2007 Apr; 19(4):545-56. PubMed ID: 17329233
[TBL] [Abstract][Full Text] [Related]
36. NK cell enhancement of antigen presentation by B lymphocytes.
Jennings P; Yuan D
J Immunol; 2009 Mar; 182(5):2879-87. PubMed ID: 19234183
[TBL] [Abstract][Full Text] [Related]
37. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and activity of dipeptides, linked to targeting ligands, as specific NK cell enhancers.
Abbott SD; Gagnon L; Lagraoui M; Kadhim S; Attardo G; Zacharie B; Penney CL
J Med Chem; 1998 May; 41(11):1909-26. PubMed ID: 9599240
[TBL] [Abstract][Full Text] [Related]
39. A novel large granular lymphocyte-like cell isolated from IL-2-supplemented murine intestinal lamina propria lymphocyte cultures with potent inhibitory action on lymphocyte proliferation.
Hörnqvist E; Enerbäck L; Chen XJ; Lycke N
Cell Immunol; 1993 Apr; 148(1):71-90. PubMed ID: 8495492
[TBL] [Abstract][Full Text] [Related]
40. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
